Identification of potentially effective antisense oligodeoxyribonucleotide (ODN) sequences for inhibiting plasminogen activator inhibitor-2 (PAI-2) production by monocytes

Thrombosis and Haemostasis

Volumn 88, Issue 1, 2002, Pages 131-136

  Humphries, Julia ^a   Burnand, Kevin G ^a   Cunningham, Philip ^a   Brock, Adrian ^a   Westwood, Nigel ^a   Smith, Alberto ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antisense oligodeoxynucleotides; Monocyte; Plasminogen activator inhibitor 2 (PAI 2)

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BIOTIN; LIPOSOME; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE PROTEINASE INHIBITOR;

ARTICLE; CALCULATION; CELL FREE SYSTEM; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; FLUOROMETRY; GENETIC TRANSCRIPTION AND TRANSLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN SYNTHESIS INHIBITION; REFERENCE VALUE; RETICULOCYTE LYSATE; SCREENING TEST; SEQUENCE ANALYSIS; BIOSYNTHESIS; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION; GENETICS; METABOLISM;

CELL-FREE SYSTEM; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION; HUMANS; MONOCYTES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE PROTEINASE INHIBITORS; TRANSFECTION;

EID: 0036301540     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613165     Document Type: Article

References (49)

1. Plasminogen activation and regulation of pericellular proteolysis
2. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos
3. Interleukin-4 stimulates human monocytes to produce tissue-type plasminogen activator
4. Lipopolysaccharide-induced modulation of human monocyte urokinase production and activity
5. Detection of both type 1 and type 2 plasminogen activator inhibitors in human monocytes
6. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages
7. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase
8. A fibrinolytic inhibitor of human alveolar macrophages. Induction with endotoxin
9. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function
10. Biological and clinical aspects of plasminogen activator inhibitor type 2
11. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia
12. The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival
13. The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus
14. Tissue plasminogen activator production by monocytes in venous thrombolysis
15. Inhibition of rabbit beta-globin synthesis by complementary oligonucleotides: Identification of mRNA sites sensitive to inhibition
16. Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: Specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis
17. Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant
18. A method for screening antisense oligodeoxyribonucleotides effective for mRNA translation-arrest
19. Specific inhibition of delta antigen by in vitro system by antisense oligodeoxynucleotide: Implications for translation mechanism and treatment
20. Thrombin inhibits apoptosis of monocytes and plasminogen activator inhibitor 2 (PAI-2) is not responsible for this inhibition
21. A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes
22. Effect of TNF-alpha antisense oligomers on cytokine production by primary murine alveolar macrophages
23. Antisense inhibition of silica-induced tumor necrosis factor in alveolar macrophages
24. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries
25. The folding of large RNAs studied by hybridization to arrays of complementary oligonucleotides
26. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16
27. Selecting effective antisense reagents on combinatorial oligonucleotide arrays
28. Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides
29. Interpreting cDNA sequences: Some insights from studies on translation
30. Increased release of plasminogen activator inhibitor type 2 accompanies the human mononuclear cell tissue factor response to lipopolysaccharide
31. Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: Dependence on phosphorothioate modification and reversal by heparin
32. The delivery of antisense therapeutics
33. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes
34. High-efficiency stable gene transfection using chloroquine-treated Chinese hamster ovary cells
35. High efficiency polyoma DNA transfection of chloroquine treated cells
36. Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset
37. Intercellular adhesion molecular 1 on monocytes mediates adhesion as well as trans-endothelial migration and can be downregulated using antisense oligonucleotides
38. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth
39. Antisense oligodeoxynucleotides targeting internal exon sequences efficiently regulate TNF-alpha expression
40. Transfection of small numbers of human endothelial cells by electroporation and synthetic amphiphiles
41. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers
42. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers
43. Trojan peptides: The penetratin system for intracellular delivery
44. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
45. Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide
46. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: Characterization of P(LA-GA) copolymer microspheres in vitro
47. Receptor-mediated gene transfer into macrophages
48. Transfer of the human Alpha1-antitrypsin gene into pulmonary macrophages in vivo
49. Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis